Craig Fraser's Net Worth

$5.44 Thousand

Estimate Recalculated Feb 7, 2024 04:01PM EST

Who is Craig Fraser?

Craig Fraser does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include WINDTREE THERAPEUTICS INC /DE/, and Aegerion Pharmaceuticals, Inc..

SEC CIK

Craig Fraser's CIK is 0001557420

Past Insider Trading and Trends

2021 was Craig Fraser's most active year for acquiring shares with 14 total transactions. Craig Fraser's most active month to acquire stocks was the month of January. 2019 was Craig Fraser's most active year for disposing of shares, totalling 6 transactions. Craig Fraser's most active month to dispose stocks was the month of January. 2016 saw Craig Fraser paying a total of $17,461.54 for 253,441 shares, this is the most they've acquired in one year. In 2018 Craig Fraser cashed out on 15,560 shares for a total of $77,765.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $0.3484

President and CEO

Craig Fraser owns 58,955 units of Common Stock which is worth $20,539.92. From 2016 to 2023 Craig Fraser acquired a total of 2,442,596 shares in WINDTREE THERAPEUTICS INC /DE/ at a cost of $92,869.81, Craig also disposed a total of 255,644 shares of WINDTREE THERAPEUTICS INC /DE/ equalling to $77,765.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.51%
2.5K
$1.02
$2,549.75
57.88K
Sep 27
Form 4
+4.73%
2.5K
$0.90
$2,250.00
55.38K
Sep 26
Form 4
+654.31%
45.87K
—
—
52.88K
Aug 23
Form 4
+27.15%
1.5K
$1.77
$2,649.69
7.01K
Apr 26
Form 4
+31.32%
1.31K
$1.89
$2,485.35
5.51K
Apr 25
Form 4
-7.37%
-334.00
—
—
4.2K
Feb 28
Form 4
+1.12%
2.5K
$0.38
$949.75
226.56K
Jul 27
Form 4
+1.13%
2.5K
$0.37
$935.00
224.06K
Jul 26
Form 4
+2.07%
4.5K
$0.43
$1,925.55
221.56K
Jun 30
Form 4
+3.33%
7K
$0.42
$2,907.80
217.06K
Jun 29
Form 4
+0.96%
2K
$0.98
$1,959.80
210.06K
Mar 16
Form 4
+1.46%
3K
$0.98
$2,940.30
208.06K
Mar 15
Form 4
+437.39%
166.9K
—
—
205.06K
Mar 4
Form 4
+2.50%
930
$1.60
$1,488.00
38.16K
Nov 19
Form 4
+2.56%
930
$1.61
$1,497.30
37.23K
Nov 18
Form 4
+9.01%
3K
$1.90
$5,700.00
36.3K
Oct 22
Form 4
+9.90%
3K
$1.91
$5,730.00
33.3K
Oct 19
Form 4
+3.41%
1K
$2.09
$2,092.00
30.3K
Apr 16
Form 4
+3.53%
1K
$2.24
$2,239.90
29.3K
Apr 15
Form 4
+1.80%
500
$2.57
$1,285.00
28.3K
Apr 6
Form 4
+3.73%
1K
$2.58
$2,579.90
27.8K
Apr 5
Form 4
+1.90%
500
$2.46
$1,229.35
26.8K
Apr 1
Form 4
+1.94%
500
$2.32
$1,159.95
26.3K
Mar 31
Form 4
+6.17%
1.5K
$3.25
$4,875.00
25.8K
Mar 25
Form 4
—
0
—
—
0
Jan 22
Form 4
+1.04%
250
$6.56
$1,639.88
24.3K
Oct 28
Form 4
+1.05%
250
$5.83
$1,456.25
24.05K
Oct 9
Form 4
+1.06%
250
$5.17
$1,292.50
23.8K
Oct 7
Form 4
+9.63%
2.07K
$7.25
$15,000.25
23.55K
May 22
Form 4/A
-22.15%
-18.02K
—
—
63.34K
Mar 15
Form 4/A
-3.12%
-2.62K
—
—
81.36K
Feb 7
Form 4
+0.79%
500
$4.10
$2,050.00
63.59K
Feb 10 - Feb 11
Form 4
+0.96%
600
$4.23
$2,540.00
63.09K
Feb 3 - Feb 4
Form 4
—
0
—
—
0
Mar 19
Form 4
-24.83%
-20.64K
—
—
62.49K
Mar 15
Form 4
-1.01%
-851.00
—
—
83.13K
Feb 7
Form 4
-15.63%
-15.55K
$5.00
-$77,765.00
83.98K
Dec 28
Form 4
—
0
—
—
0
Dec 24
Form 4
+0.35%
350
—
—
99.53K
Nov 21
Form 4
+26,349.20%
1.98M
—
—
1.98M
Nov 1
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Feb 13
Form 4
∞
7.5K
$2.05
$15,381.00
7.5K
Oct 28
Form 4
∞
1.08K
$1.93
$2,080.54
1.08K
Jun 30 - Jul 28
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found

Aegerion Pharmaceuticals, Inc. No price found

Pres., US/Int. Comm. & Manuf.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found